All Releases
View Summary Celldex Therapeutics Added to Nasdaq Biotechnology Index
May 15, 2012
PDF 18.2 KB Add to Briefcase
View Summary Celldex Reports First Quarter 2012 Financial Results
May 3, 2012
PDF 26.7 KB Add to Briefcase
View Summary Celldex Announces Plans to Release Topline Results from the EMERGE Study in Advanced Breast Cancer
May 1, 2012
PDF 19.8 KB Add to Briefcase
View Summary Celldex Announces Exercise of Over-Allotment Option
Mar 14, 2012
PDF 17.7 KB Add to Briefcase
View Summary Celldex Reports Fourth Quarter and Fiscal 2011 Financial Results
Mar 7, 2012
PDF 34.9 KB Add to Briefcase
View Summary Celldex Therapeutics to Host Corporate 2011 Year-End and 2012 Objectives Update Call
Feb 29, 2012
PDF 15.5 KB Add to Briefcase
View Summary Celldex Therapeutics to Present at the Citi 2012 Global Health Care Conference
Feb 24, 2012
PDF 17.9 KB Add to Briefcase
View Summary Celldex Prices Public Offering of Common Stock
Feb 24, 2012
PDF 18.0 KB Add to Briefcase
View Summary Celldex Announces Public Offering of Common Stock
Feb 23, 2012
PDF 18.1 KB Add to Briefcase
View Summary Celldex Therapeutics to Participate on Therapeutic Workshop Panel at the BIO CEO & Investor Conference
Feb 9, 2012
PDF 17.8 KB Add to Briefcase
View Summary Celldex Therapeutics to Host Research and Development Day Highlighting Oncology Pipeline
Jan 18, 2012
PDF 16.6 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Initiation of Phase 1 Clinical Trial of CDX-301
Jan 17, 2012
PDF 19.1 KB Add to Briefcase
View Summary Celldex Initiates a Phase 2 Study of Rindopepimut in Patients with Recurrent Glioblastoma including Avastin® Naive and Refractory Populations
Jan 4, 2012
PDF 20.8 KB Add to Briefcase
Showing 141-153 of 153 Page: 1 ... 4 5 6 7 8  Previous 20
Showing 141-153 of 153
Page: 1 ... 4 5 6 7 8
 Previous 20
Add to Briefcase = add release to Briefcase